“Weiyu Capital has completed the eighth phase of fundraising. We will invest half of this 750 million US dollars in the Chinese market, focusing on life sciences and medical health industry companies that have entered the growth stage.†Professor of Stanford University School of Medicine Ying Geming, one of the founders of Wei Wei Capital, announced in Shanghai recently.
With the rapid growth of China's medical market, some companies with good growth and investment value have begun to emerge. The fast-growing and promising Chinese healthcare market is attracting more and more international capital.
According to reports, Weiwei Capital has completed seven cross-border cooperation projects in the Chinese market, and has several successful exit cases such as the reverse acquisition of Haijingfeng Pharmaceutical.
The data shows that in the past three years, China's medical health expenditure has grown at an average annual rate of 13.2%, making it the second largest health industry market in the world after the United States. It is estimated that by 2020, the total size of China's health service industry will reach 8 trillion yuan.
Statistics show that in 2014, China's medical and health market completed a total of 142 cross-border mergers and acquisitions, involving a total transaction volume of 40.2 billion yuan. At the "2015 China Medical Health Investment Summit" held in Shanghai earlier this month, participants generally said that China's medical and health field has become "a rising star in the global investment community."
In the huge Chinese healthcare market, investment opportunities in e-health and mobile healthcare platforms have gained more attention from overseas capital.
Following the two sessions this year, after the Chinese government wrote “Internet +†into the government work report, the “National Health Service System Planning Outline†promulgated at the end of March proposed the “Healthy China Cloud Service Planâ€, including the active application of the mobile Internet and the Internet of Things. New technologies such as cloud computing and wearable devices are being promoted to promote health information services and smart medical services that benefit the entire population and promote the application of healthy big data.
In 2014, the scale of China's mobile medical market jumped fourfold from the previous year. The China Medical Materials Association estimates that this scale is expected to reach RMB 12.5 billion in 2017. The China Mobile Medical Market Research Report 2014 predicts that the total investment in China's e-health sector will reach RMB 17.24 billion in 2018.
In the view of Lecheng, a partner at McKinsey and head of the medical industry in Greater China, the changes in China's e-health and mobile healthcare markets will drive a shift in business models. Kong Fanjian, founder of Weiwei Capital, revealed that the fast-rising mobile medical industry will become one of the key investment areas of Weifang Capital in China.
“We hope to invest in companies that are looking for a light asset business model, especially in the professional services sector that can complement and optimize China's existing medical service resources,†said Kong Fanjian.
Fungi, a large class of chlorophyll - free, can not carry out photosynthesis, heterotrophic lower class of plants. These include bacteria, slime molds and fungi. Their common characteristics are: the plant body has no differentiation of roots, stems and leaves, does not contain chlorophyll and other photosynthetic pigments (except a few photosynthetic bacteria), can not carry out photosynthesis, saprophytic life or parasitic life, that is, heterotrophic life. Most of the reproductive organs are single-cell structures, and the zygotes do not develop into embryos.
Ganoderma Lucidum Extract,Lion's Mane mushroom Extract,Chaga Mushroom Extract
Xi'an Double H Health Technology Co., Ltd , https://www.xadoubleh.com